Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-05-28
1989-02-07
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514518, 514551, 558 37, 560173, 544154, C07C10102
Patent
active
048032018
ABSTRACT:
Aphidicolane derivatives of the formula: ##STR1## wherein R.sup.1 stands for hydrogen or a hydroxy radical, R.sup.2 stands for a hydroxy or methyl radical, or the group CR.sup.1 R.sup.2 stands for a keto group; R.sup.3 stands for a formyl or hydroxymethyl radical, or for the group --CH.sub.2 O.CO.OR.sup.6, wherein R.sup.6 stands for a defined radical or R.sup.2 and R.sup.3 are joined together to form the group --O.CO.OCH.sub.2 --; R.sup.4 stands for a hydroxy radical; R.sup.5 stands for a formyl radical, a hydroxyalkyl radical --(CH.sub.2).sub.1-3 OH, a radical --CHR.sup.7 OH, wherein R.sup.7 stands for a defined radical, or R.sup.5 stands for an azidomethyl or pyrrolidinylcarbonyloxymethyl radical, or for the group --CH.sub.2 O.CO.OR.sup.8, wherein R.sup.8 stands for a defined radical, or R.sup.5 stands for the group --CH.sub.2 O.CO.(CH.sub.2).sub.m.CR.sup.11 R.sup.12.(CH.sub.2).sub.n.NR.sup.9 R.sup.10, wherein m, n, R.sup.9, R.sup.10, R.sup.11 and R.sup.12 have defined values, or R.sup.5 stands for the group --CH.sub.2 O.SO.sub.2.R.sup.13, wherein R.sup.13 stands for a defined radical; or R.sup.4 and R.sup.5 are joined together to form the group --O.CH.sub.2 -- or --O.CO.OCH.sub.2 --; and, where appropriate, pharmaceutically-acceptable salts thereof. Processes for the preparation of said aphidicolane derivatives. Pharmaceutical compositions comprising one of the compounds and a pharmaceutical diluent or carrier. The compounds exhibit inhibitory activity against DNA-containing viruses and they inhibit the growth of some tumors.
REFERENCES:
Roche, "Design of Biopharmaceutical Properties Through Prodrugs and Analogs," pp. 27-46 & 281-315 (1977).
The Journal of Organic Chemistry, vol. 47, No. 17, Aug. 13, 1982, J. Ipsen, J. Fuska, A. Foskova and J. P. Rosazza, pp. 3278-3282, Microbial Transformations of Natural Antitumor Agents, 21. Conversions of Aphidicolin.
The Extra Pharmacopoeia, Twenty-Seventh Edition, Edited by Ainley Wade, pp. (preface) XIV-XV.
Imperial Chemical Industries plc
Shippen Michael L.
LandOfFree
Homocyclic derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Homocyclic derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Homocyclic derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1084921